23
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Investigation of Sustained Release of 5- Fluoro Uracil Drug from Chitosan-co-Lactic acid Nanoparticles

, &
Pages 271-283 | Received 21 Sep 2019, Accepted 23 Feb 2021, Published online: 04 May 2021
 

Abstract

There are several anticancer drugs that are sparingly soluble in water and, therefore, one needs to explore novel kind of drug delivery systems for these drugs. In this work, we have reported the synthesis of chitosan-co-lactic acid nanoparticles and evaluated how efficiently do they deliver 5- Fluoro uracil drug. The prepared nanoparticles were loaded with 5- Fluoro uracil and in vitro kinetics of 5- Fluoro uracil was studied spectrophotometrically at physiological pH (7.4) and room temperature. The cumulative drug release was found to increase with increasing percent loading. The influences of experimental parameters like simulated physiological fluids, temperature, varying chemical composition of the chitosan-co-lactic acid nanoparticles, temperature, and pH of the release medium were studied on the release kinetics of the drug. An optimum drug release was obtained in the PBS as compared to other simulated fluids. In the case of temperature, the drug release increased up to 30°C while it decreased with further increase in temperature. In the case of chitosan and lactic acid, an optimum cumulative drug release was observed at the definite composition of chitosan and lactic acid. By using Fick’s law equation, the diffusional exponents (n) were evaluated for different compositions of nanoparticles. The kind of drug release process of 5- Fluoro uracil was analyzed by using the kinetic data.

GRAPHICAL ABSTRACT

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.